Community Healthcare Trust (CHCT) 10-Q 4 Aug 20 2020 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2020	Jul. 31, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2020
Document Transition Report	false
Entity File Number	001-37401
Entity Registrant Name	Community Healthcare Trust Inc
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	46-5212033
Entity Address, Address Line One	3326 Aspen Grove Drive
Entity Address, Address Line Two	Suite 150
Entity Address, City or Town	Franklin
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37067
City Area Code	615
Local Phone Number	771-3052
Title of 12(b) Security	Common stock, $0.01 par value per share
Trading Symbol	CHCT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		22,726,373
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001631569
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Real estate properties
Land and land improvements	$ 78,999	$ 68,129
Buildings, improvements, and lease intangibles	585,454	534,503
Personal property	234	220
Total real estate properties	664,687	602,852
Less accumulated depreciation	(89,698)	(77,523)
Total real estate properties, net	574,989	525,329
Cash and cash equivalents	4,896	1,730
Restricted cash	351	293
Other assets, net	32,068	35,179
Total assets	612,304	562,531
Liabilities
Debt, net	197,309	194,243
Accounts payable and accrued liabilities	5,497	3,606
Other liabilities	22,395	11,271
Total liabilities	225,201	209,120
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding	0	0
Common stock, $0.01 par value; 450,000,000 shares authorized; 22,726,141 and 21,410,578 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively	227	214
Additional paid-in capital	500,477	447,916
Cumulative net income	26,180	17,554
Accumulated other comprehensive loss	(13,969)	(4,808)
Cumulative dividends	(125,812)	(107,465)
Total stockholders’ equity	387,103	353,411
Total liabilities and stockholders' equity	$ 612,304	$ 562,531

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred Stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred Stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common Stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common Stock, shares authorized (in shares)	450,000,000	450,000,000
Common Stock, shares issued (in shares)	22,726,141	21,410,578
Common Stock, shares outstanding (in shares)	22,726,141	21,410,578

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
REVENUES
Rental income	$ 17,830	$ 13,361	$ 35,258	$ 26,259
Other operating interest	450	955	958	1,498
Revenues	18,280	14,316	36,216	27,757
EXPENSES
Property operating	3,223	2,993	6,566	6,068
General and administrative	1,919	1,776	4,111	3,561
Depreciation and amortization	6,119	5,299	12,178	10,545
EXPENSES	11,261	10,068	22,855	20,174
Loss on sale of real estate	(313)	0	(313)	0
Interest expense	(2,183)	(2,251)	(4,432)	(4,305)
Interest and other income, net	3	69	10	238
OTHER INCOME (EXPENSE)	(2,493)	(2,182)	(4,735)	(4,067)
NET INCOME	$ 4,526	$ 2,066	$ 8,626	$ 3,516
NET INCOME PER COMMON SHARE:
Net income per common share – Basic (in dollars per share)	$ 0.19	$ 0.09	$ 0.37	$ 0.16
Net income per common share – Diluted (in dollars per share)	$ 0.19	$ 0.09	$ 0.37	$ 0.16
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-BASIC (in shares)	21,263,575	18,245,668	20,999,097	18,100,973
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING-DILUTED (in shares)	21,263,575	18,245,668	20,999,097	18,100,973

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 4,526	$ 2,066	$ 8,626	$ 3,516
Other comprehensive (loss) income:
Decrease in fair value of cash flow hedges	(1,317)	(4,032)	(10,193)	(5,245)
Reclassification for amounts recognized as interest expense	774	(95)	1,032	(157)
Total other comprehensive loss	(543)	(4,127)	(9,161)	(5,402)
COMPREHENSIVE INCOME (LOSS)	$ 3,983	$ (2,061)	$ (535)	$ (1,886)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid in Capital	Cumulative Net Income	Accumulated Other Comprehensive (Loss) Income	Cumulative Dividends
Beginning Balance (in shares) at Dec. 31, 2018		18,634,502
Beginning Balance at Dec. 31, 2018	$ 271,659	$ 186	$ 337,180	$ 9,178	$ 633	$ (75,518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		641,053
Issuance of common stock, net of issuance costs	22,992	$ 7	22,985
Stock-based compensation (in shares)		125,689
Stock-based compensation	1,749	$ 1	1,748
Unrecognized loss on cash flow hedges	(5,245)				(5,245)
Reclassification adjustment for losses included in net income (interest expense)	(157)				(157)
Net income	3,516			3,516
Dividends to common stockholders	(15,394)					(15,394)
Ending Balance (in shares) at Jun. 30, 2019		19,401,244
Ending Balance at Jun. 30, 2019	279,120	$ 194	361,913	12,694	(4,769)	(90,912)
Beginning Balance (in shares) at Dec. 31, 2018		18,634,502
Beginning Balance at Dec. 31, 2018	$ 271,659	$ 186	337,180	9,178	633	(75,518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	2,554,247
Ending Balance (in shares) at Dec. 31, 2019		21,410,578
Ending Balance at Dec. 31, 2019	$ 353,411	$ 214	447,916	17,554	(4,808)	(107,465)
Beginning Balance (in shares) at Mar. 31, 2019		18,862,792
Beginning Balance at Mar. 31, 2019	269,683	$ 189	342,654	10,628	(642)	(83,146)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		497,453
Issuance of common stock, net of issuance costs	18,368	$ 5	18,363
Stock-based compensation (in shares)		40,999
Stock-based compensation	896	$ 0	896
Unrecognized loss on cash flow hedges	(4,032)				(4,032)
Reclassification adjustment for losses included in net income (interest expense)	(95)				(95)
Net income	2,066			2,066
Dividends to common stockholders	(7,766)					(7,766)
Ending Balance (in shares) at Jun. 30, 2019		19,401,244
Ending Balance at Jun. 30, 2019	279,120	$ 194	361,913	12,694	(4,769)	(90,912)
Beginning Balance (in shares) at Dec. 31, 2019		21,410,578
Beginning Balance at Dec. 31, 2019	$ 353,411	$ 214	447,916	17,554	(4,808)	(107,465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)	1,189,545	1,189,545
Issuance of common stock, net of issuance costs	$ 50,492	$ 12	50,480
Stock-based compensation (in shares)		126,018
Stock-based compensation	2,082	$ 1	2,081
Unrecognized loss on cash flow hedges	(10,193)				(10,193)
Reclassification adjustment for losses included in net income (interest expense)	1,032				1,032
Net income	8,626			8,626
Dividends to common stockholders	(18,347)					(18,347)
Ending Balance (in shares) at Jun. 30, 2020		22,726,141
Ending Balance at Jun. 30, 2020	387,103	$ 227	500,477	26,180	(13,969)	(125,812)
Beginning Balance (in shares) at Mar. 31, 2020		22,125,269
Beginning Balance at Mar. 31, 2020	367,775	$ 221	475,824	21,654	(13,426)	(116,498)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs (in shares)		578,759
Issuance of common stock, net of issuance costs	23,590	$ 6	23,584
Stock-based compensation (in shares)		22,113
Stock-based compensation	1,069	$ 0	1,069
Unrecognized loss on cash flow hedges	(1,317)				(1,317)
Reclassification adjustment for losses included in net income (interest expense)	774				774
Net income	4,526			4,526
Dividends to common stockholders	(9,314)					(9,314)
Ending Balance (in shares) at Jun. 30, 2020		22,726,141
Ending Balance at Jun. 30, 2020	$ 387,103	$ 227	$ 500,477	$ 26,180	$ (13,969)	$ (125,812)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity Condensed Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Cumulative Dividends
Dividends to common stockholders, per share (in dollars per share)	$ 0.42	$ 0.41	$ 0.8375	$ 0.8175

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
OPERATING ACTIVITIES
Net income	$ 8,626	$ 3,516
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	12,178	10,545
Other amortization	(224)	294
Stock-based compensation	2,082	1,749
Straight-line rent receivable	(1,604)	(749)
Loss on sale of real estate	313	0
Deferred income tax expense	20	27
Changes in operating assets and liabilities:
Other assets	(119)	(1,087)
Accounts payable and accrued liabilities	1,089	114
Other liabilities	1,386	(26)
Net cash provided by operating activities	23,747	14,383
INVESTING ACTIVITIES
Acquisitions of real estate	(57,890)	(63,449)
Proceeds from sale of real estate	248	0
Acquisition of note receivable	(1,750)	0
Proceeds from the repayment of notes receivable	6,910	320
Capital expenditures on existing real estate properties	(3,081)	(1,654)
Net cash used in investing activities	(55,563)	(64,783)
FINANCING ACTIVITIES
Net borrowings (repayments) on revolving credit facility	3,000
Net borrowings (repayments) on revolving credit facility		(24,000)
Term loan borrowings	0	75,000
Mortgage note repayments	(53)	(52)
Dividends paid	(18,347)	(15,394)
Proceeds from issuance of common stock	50,579	23,172
Equity issuance costs	(139)	(180)
Debt issuance costs	0	(1,273)
Net cash provided by financing activities	35,040	57,273
Increase in cash and cash equivalents and restricted cash	3,224	6,873
Cash and cash equivalents and restricted cash, beginning of period	2,023	2,392
Cash and cash equivalents and restricted cash, end of period	5,247	9,265
Supplemental Cash Flow Information:
Interest paid	3,110	2,781
Invoices accrued for construction, tenant improvement and other capitalized costs	707	29
Reclassification between accounts and notes receivable	0	45
Reclassification of registration statement costs incurred in prior year to equity issuance costs	95	187
Decrease in fair value of cash flow hedges	(10,193)	(5,245)
Income taxes paid	$ 31	$ 0

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Community Healthcare Trust Incorporated (the ‘‘Company’’, ‘‘we’’, ‘‘our’’) was organized in the State of Maryland on March 28, 2014. The Company is a fully-integrated healthcare real estate company that owns and acquires real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. As of June 30, 2020 , the Company had investments of approximately $664.7 million in 131 real estate properties, located in 33 states, totaling approximately 2.8 million square feet in the aggregate. Any references to square footage or occupancy percentages, and any amounts derived from these values in these notes to the condensed consolidated financial statements, are outside the scope of our independent registered public accounting firm's review. Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2020 . All material intercompany accounts and transactions have been eliminated. A novel strain of coronavirus (SARS-CoV-2) was first identified in late 2019, and subsequently declared a global pandemic by the World Health Organization ("COVID-19"). The Company considered the impact of the COVID-19 on the assumptions and estimates used for the three and six months ended June 30, 2020 . The full extent of the future impacts of COVID-19 on the Company's operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company. During the second quarter of 2020, the Company has provided lease concessions to certain tenants in response to the impact of COVID-19, in the form of rent deferrals. The Company has made an election to account for such lease concessions consistent with how those concessions would be accounted for under the current leasing guidance if enforceable rights and obligations for those concessions had already existed in the leases. This election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in our rights as lessor, including concessions that result in the total payments required by the modified lease being substantially the same as or less than total payments required by the original lease. All of the Company’s concessions to date provide for a deferral of payments with no substantive changes to the consideration in the original lease. These deferrals affect the timing, but not the amount, of the lease payments. The Company is accounting for these deferrals as if no changes to the lease were made. Under this accounting, the Company increases its lease receivable as tenant payments accrue and continues to recognize rental income. As of July 31, 2020, the Company has entered into, or anticipates entering into, deferral agreements with up to approximately 20 tenants representing less than one percent of our annualized rent. Pursuant to these agreements, the tenants are generally required to repay the deferred amounts in equal monthly installments during the third and fourth quarters of 2020. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents includes short-term investments with original maturities of three months or less when purchased. Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amount approximates fair value due to the short term maturity of these investments. The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of June 30, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 4,896 $ 9,031 Restricted cash 351 234 Cash, cash equivalents and restricted cash $ 5,247 $ 9,265 Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES" Act) was enacted into law and was immediately effective. The CARES Act includes several tax provisions that allow for the carryback of net operating losses, provides relief from the taxable income limitation on the use of net operating losses carried forward, increases the business interest limitation from 30% to 50%, makes technical corrections to tax depreciation methods for qualified improvement property, and provides payroll tax credits and for the deferral of employer social security payments. The Company does not believe that there have been or will be material impacts to its income taxes related to the CARES Act. The Company will continue to evaluate the tax impact of the CARES Act and any guidance provided by the U.S. Treasury and Internal Revenue Service. New Accounting Pronouncements Recently Adopted Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies are required to use a new current expected credit loss ("CECL") model that generally results in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies are required to measure credit losses in a manner similar to prior guidance, except that the losses are recognized as allowances rather than as reductions in the amortized cost of the securities. In November 2018, the FASB amended the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. Companies have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies must apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company adopted ASU No. 2016-13 on January 1, 2020. The Company did not record an adjustment upon adoption as the impact was determined to be immaterial. However, this standard could impact the Company's financial statements and results of operations in future periods. Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform

Real Estate Leases

Real Estate Leases	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Real Estate Leases	Real Estate Leases The Company’s properties are generally leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2035 . The Company’s leases generally require the lessee to pay minimum rent, with fixed rent renewal terms or increases based on a Consumer Price Index and may also include additional rent, which may include taxes (including property taxes), insurance, maintenance and other operating costs associated with the leased property. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. Some leases also allow the lessee to renew or extend their lease term or in some cases terminate their lease, based on conditions provided in the lease. Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of June 30, 2020 , are as follows (in thousands): 2020 (six months ending December 31) $ 30,417 2021 58,659 2022 55,024 2023 49,996 2024 46,867 2025 and thereafter 299,485 $ 540,448 Straight-line rental income Rental income is recognized as earned over the life of the lease agreement on a straight-line basis when collection of rental payments over the term of the lease is probable. Straight-line rent included in rental income was approximately $0.7 million and $0.4 million , respectively, for the three months ended June 30, 2020 and 2019 . Straight-line rent included in rental income was approximately $1.6 million and $0.7 million , respectively, for the six months ended June 30, 2020 and 2019 . Deferred revenue Income received but not yet earned is deferred until such time it is earned. Deferred revenue, included in other liabilities on the Condensed Consolidated Balance Sheet, was approximately $ 2.1 million and $2.0 million , respectively, at June 30, 2020 and December 31, 2019 . Security Deposits As of June 30, 2020 and December 31, 2019 , the Company held approximately $4.1 million and $3.5 million , respectively, in security deposits for the benefit of the Company in the event the obligated tenant fails to perform under the terms of its respective lease. Generally, the Company may, at its discretion and upon notification to the tenant, draw upon the security deposits if there are any defaults under the leases.

Real Estate Acquisitions and Di

Real Estate Acquisitions and Dispositions	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Real Estate Acquisitions and Dispositions	Real Estate Acquisitions and Dispositions 2020 Real Estate Acquisitions During the second quarter of 2020 , the Company acquired seven real estate properties and a land parcel adjacent to one of our existing properties to be used for additional parking. Upon acquisition, the real estate properties were 100% leased in the aggregate with lease expirations through 2035 . Amounts reflected in revenues and net income for these properties for the three months ended June 30, 2020 were approximately $0.1 million and four thousand dollars, respectively, and transaction costs totaling approximately $0.4 million were capitalized relating to these property acquisitions. During the first quarter of 2020 , the Company acquired six real estate properties. Upon acquisition, the properties were 98.2% leased in the aggregate with lease expirations through 2035 . Amounts reflected in revenues and net income for these properties for the six months ended June 30, 2020 were approximately $1.4 million and $0.8 million , respectively, and transaction costs totaling approximately $0.2 million were capitalized relating to these property acquisitions. Location Property Type (1) Date Acquired Purchase Price Cash Consideration Real Estate Other (2) Square Footage (000's) (000's) (000's) (000's) San Antonio, TX MOB 01/27/20 $ 4,003 $ 4,022 $ 4,036 $ (14 ) 13,500 San Antonio, TX MOB 01/27/20 1,931 1,955 1,961 (6 ) 6,500 Decatur, AL MOB 02/18/20 5,784 5,792 5,777 15 35,943 Ramona, CA SC 03/13/20 4,100 4,124 4,143 (19 ) 11,300 Cuero, TX SC 03/18/20 2,153 2,174 2,207 (33 ) 15,515 Rogers, AR IRF 03/27/20 19,000 18,317 19,042 (725 ) 38,817 Oak Lawn, IL (land) MOB 04/20/20 400 403 421 (18 ) — Germantown, TN SC 04/29/20 3,900 3,949 3,949 — 10,600 Westlake, OH SC 06/05/20 2,443 2,456 2,487 (31 ) 15,057 Columbus, IN (3) SC 06/05/20 1,813 1,828 1,787 41 13,969 Niceville, FL MOB 06/15/20 2,294 2,340 2,344 (4 ) 10,250 Greensburg, PA MOB 06/16/20 3,389 3,484 3,497 (13 ) 15,650 Gardendale, AL MOB 06/24/20 2,948 2,935 2,878 57 12,956 Prattville, AL MOB 06/24/20 4,091 4,111 4,078 33 13,319 $ 58,249 $ 57,890 $ 58,607 $ (717 ) 213,376 (1) MOB - Medical Office Building; SC - Specialty Center; IRF - Inpatient Rehabilitation Facility (2) Includes, but is not limited to, above- and below-market lease intangibles, liabilities assumed, and security deposits. (3) The Company assumed a ground lease in connection with this acquisition that is classified as an operating lease. The present value of future lease payments and the right-of-use asset, each totaling approximately $0.2 million, are included in other liabilities and other assets, respectively, on the Company's Condensed Consolidated Balance Sheets. The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the six months ended June 30, 2020 . Relative Fair Value Estimated Useful Life (in thousands) (in years) Land and land improvements $ 11,323 8.5 Building and building improvements 41,709 30.2 Intangibles: At-market lease intangibles 5,575 5.4 Above-market lease intangibles 292 4.8 Below-market lease intangibles (111 ) 3.1 Total intangibles 5,756 Accounts receivable and other assets assumed 247 Accounts payable, accrued liabilities and other liabilities assumed (807 ) Prorated rent, interest and operating expense reimbursement amounts collected (338 ) Total cash consideration $ 57,890 2020 Real Estate Disposition During the second quarter of 2020 , the Company sold a land parcel related to one of its properties for approximately $0.3 million and recognized a loss on sale of approximately $0.3 million .

Debt, net

Debt, net	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Debt, net	Debt, net The table below details the Company's debt as of June 30, 2020 and December 31, 2019 . Balance as of (Dollars in thousands) June 30, 2020 December 31, 2019 Maturity Dates Revolving Credit Facility $ 18,000 $ 15,000 3/23 A-1 Term Loan, net 49,871 49,833 3/22 A-2 Term Loan, net 49,801 49,775 3/24 A-3 Term Loan, net 74,479 74,433 3/26 Mortgage Note Payable, net 5,158 5,202 5/24 $ 197,309 $ 194,243 The Company's second amended and restated credit facility (the "Credit Facility") is by and among Community Healthcare OP, LP, the Company, and a syndicate of lenders with Truist Bank (formerly SunTrust Bank) serving as Administrative Agent. The Company’s material subsidiaries are guarantors of the obligations under the Credit Facility. The Credit Facility, as amended, provides for a $150.0 million Revolving Credit Facility and $175.0 million in term loans (the "Term Loans"). The Credit Facility, through the accordion feature, allows borrowings up to a total of $525.0 million including the ability to add and fund additional term loans. The Revolving Credit Facility matures on March 29, 2023 and includes one 12 -month option to extend the maturity date of the Revolving Credit Facility, subject to the satisfaction of certain conditions. The Term Loans include a five -year term loan facility in the aggregate principal amount of $50.0 million (the "A-1 Term Loan"), which matures on March 29, 2022 , a seven -year term loan facility in the aggregate principal amount of $50.0 million (the "A-2 Term Loan"), which matures on March 29, 2024 , and a seven -year, term loan facility in the aggregate principal amount of $75.0 million (the "A-3 Term Loan"), which matures on March 29, 2026 . Amounts outstanding under the Revolving Credit Facility, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 1.90% or (ii) a base rate plus 0.25% to 0.90% in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.25% of the amount of the unused portion of the Revolving Credit Facility if amounts borrowed are greater than 33.3% of the borrowing capacity under the Revolving Credit Facility and 0.35% of the unused portion of the Revolving Credit Facility if amounts borrowed are less than or equal to 33.3% of the borrowing capacity under the Revolving Credit Facility. The Company had $18.0 million outstanding under the Revolving Credit Facility with a 2.06% weighted average interest rate at June 30, 2020 , and a borrowing capacity remaining of approximately $132.0 million at June 30, 2020 . Amounts outstanding under the Term Loans, as amended, bear annual interest at a floating rate that is based, at the Company’s option, on either: (i) LIBOR plus 1.25% to 2.30% or (ii) a base rate plus 0.25% to 1.30% , in each case, depending upon the Company’s leverage ratio. In addition, the Company is obligated to pay an annual fee equal to 0.35% of the amount of the unused portion of the Term Loans. The Company has entered into interest rate swaps to fix the interest rates on the Term Loans. See Note 5 for more details on the interest rate swaps. At June 30, 2020 , the Company had drawn the full $175.0 million under the Term Loans which had a fixed weighted average interest rate under the swaps of approximately 4.569% . The Company’s ability to borrow under the Credit Facility is subject to its ongoing compliance with a number of customary affirmative and negative covenants, including limitations with respect to liens, indebtedness, distributions, mergers, consolidations, investments, restricted payments and asset sales, as well as financial maintenance covenants. The Company was in compliance with its financial covenants under its Credit Facility as of June 30, 2020 .

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps designated as cash flow hedges involve the receipt of variable-rate amounts if interest rates rise above the cap strike rate on the contract. As of June 30, 2020 , the Company had seven outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk for notional amounts totaling $175.0 million . The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at June 30, 2020 December 31, 2019 Balance Sheet Classification June 30, 2020 December 31, 2019 Balance Sheet Classification Interest rate swaps $ — $ — Other assets $ 13,969 $ 4,808 Other Liabilities The changes in the fair value of derivatives designated and that qualify as cash flow hedges are recorded in accumulated other comprehensive loss ("AOCI") and are subsequently reclassified to interest expense in the period that the hedged forecasted transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s Term Loans. During the next twelve months, the Company estimates that an additional $3.7 million will be reclassified from AOCI as an increase to interest expense. The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2020 and 2019 . Three Months Ended Six Months Ended (Dollars in thousands) 2020 2019 2020 2019 Amount of unrealized loss recognized in OCI on derivative $ (1,317 ) $ (4,032 ) $ (10,193 ) $ (5,245 ) Amount of loss (gain) reclassified from AOCI into interest expense $ 774 $ (95 ) $ 1,032 $ (157 ) Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,183 $ 2,251 $ 4,432 $ 4,305 Credit-risk-related Contingent Feature s As of June 30, 2020 , the fair value of derivatives in a net liability position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $14.5 million . As of June 30, 2020 , the Company has not posted any collateral related to these agreements and was not in breach of any agreement provisions. If the Company had breached any of these provisions, it could have been required to settle its obligations under the agreements at their aggregate termination value of approximately $14.5 million at June 30, 2020 .

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2020 and for the year ended December 31, 2019 : Six Months Ended Year Ended December 31, 2019 Balance, beginning of period 21,410,578 18,634,502 Issuance of common stock 1,189,545 2,554,247 Restricted stock-based awards 126,018 221,829 Balance, end of period 22,726,141 21,410,578 ATM Program On November 5, 2019, the Company entered into an Amended and Restated Sales Agency Agreement ("Amended and Restated Sales Agreement") for its at-the-market offering program ("ATM Program") with Sandler O’Neill & Partners, L.P., Evercore Group L.L.C., SunTrust Robinson Humphrey, Inc., BB&T Capital Markets, a division of BB&T Securities, LLC, Fifth Third Securities, Inc. and Janney Montgomery Scott LLC, as sales agents (collectively, the “Agents”), under which the Company may issue and sell shares of its common stock, having an aggregate gross sales price of up to $360.0 million . The shares of common stock may be sold from time to time through or to one or more of the Agents, as may be determined by the Company in its sole discretion, subject to the terms and conditions of the agreement and applicable law. The Company's activity under the ATM Program for the three and six months ended June 30, 2020 is detailed in the table below. As of June 30, 2020 , the Company had approximately $251.6 million remaining that may be issued under the ATM Program. Three Months Ended Six Months Ended Shares issued 578,759 1,189,545 Net proceeds received (in millions) $ 23.7 $ 50.6 Average gross sales price per share $ 41.70 $ 43.39

Net Income Per Common Share

Net Income Per Common Share	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Net Income Per Common Share	Net Income Per Common Share The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2020 and 2019 , respectively. Three Months Ended Six Months Ended (Dollars in thousands, except per share data) 2020 2019 2020 2019 Net income $ 4,526 $ 2,066 $ 8,626 $ 3,516 Participating securities' share in earnings (432 ) (351 ) (855 ) (652 ) Net income, less participating securities' share in earnings $ 4,094 $ 1,715 $ 7,771 $ 2,864 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 22,285,565 19,055,110 22,008,998 18,896,274 Unvested restricted shares (1,021,990 ) (809,442 ) (1,009,901 ) (795,301 ) Weighted average Common Shares outstanding–Basic 21,263,575 18,245,668 20,999,097 18,100,973 Dilutive potential common shares — — — — Weighted average Common Shares outstanding –Diluted 21,263,575 18,245,668 20,999,097 18,100,973 Basic Net Income per Common Share $ 0.19 $ 0.09 $ 0.37 $ 0.16 Diluted Net Income per Common Share $ 0.19 $ 0.09 $ 0.37 $ 0.16

Incentive Plan

Incentive Plan	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Incentive Plan	Incentive Plan A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three and six months ended June 30, 2020 and 2019 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods. Three Months Ended Six Months Ended (Dollars in thousands) 2020 2019 2020 2019 Stock-based awards, beginning of period 1,013,797 794,177 909,892 709,487 Stock in lieu of compensation 5,510 15,004 55,755 57,529 Stock awards 16,603 25,995 70,263 68,160 Total stock granted 22,113 40,999 126,018 125,689 Vested shares (15,910 ) (21,424 ) (15,910 ) (21,424 ) Stock-based awards, end of period 1,020,000 813,752 1,020,000 813,752 Amortization expense $ 1,070 $ 899 $ 2,090 $ 1,752

Other Assets, net

Other Assets, net	6 Months Ended
	Jun. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets, net	Other Assets, net Other assets, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 are detailed in the table below. Balance as of (Dollars in thousands) June 30, 2020 December 31, 2019 Notes receivable $ 18,340 $ 23,500 Lease and interest receivables 2,821 3,021 Straight-line rent receivables 6,885 5,267 Prepaid assets 602 488 Deferred financing costs, net 586 693 Leasing commissions, net 980 875 Deferred tax asset 575 595 Above-market intangible assets, net 414 144 Right-of-use leased asset 385 139 Other 480 457 $ 32,068 $ 35,179 The Company's notes receivable at June 30, 2020 included: • a loan with a borrower totaling $17.8 million which is secured by all assets and ownership interests in the operations of seven long-term acute care hospitals and one inpatient rehabilitation hospital owned by the borrower. The note matures on December 31, 2025 and bear interest at 9% per annum. The Company also has a $3.0 million revolving credit facility with the borrower that they can draw on which matures on January 1, 2026. • a $2.5 million loan, acquired by the Company for $1.75 million , to help facilitate the bankruptcy filing of a borrower. The Company subsequently received a payment of $1.2 million on the note and had a carrying balance of $0.6 million at June 30, 2020 which is secured by all assets and personal property of the borrower. The note is due on demand and bears interest at 10% per annum. The Company identified the borrowers of these notes as variable interest entities ("VIEs"), but management determined that the Company was not the primary beneficiary of the VIEs because we lack either directly or through related parties any material impact in the activities that impact the borrowers' economic performance. We are not obligated to provide support beyond our stated commitment to the borrowers, and accordingly our maximum exposure to loss as a result of this relationship is limited to the amount of our outstanding notes receivable. The VIEs that we have identified at June 30, 2020 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 17.8 $ 17.8 Note receivable $ 0.6 $ 0.6

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practical to estimate the fair value. Cash and cash equivalents and restricted cash - The carrying amount approximates the fair value. Notes receivable - The fair value is estimated using cash flow analyses, based on an assumed market rate of interest or at a rate consistent with the rates on notes carried by the Company and are classified as level 2 in the hierarchy. Borrowings under our Credit Facility - The carrying amount approximates the fair value because the borrowings are based on variable market interest rates. Derivative financial instruments - The fair value is estimated using discounted cash flow techniques. These techniques incorporate primarily level 2 inputs. The market inputs are utilized in the discounted cash flow calculation considering the instrument’s term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation model for interest rate swaps are observable in active markets and are classified as level 2 in the hierarchy. Mortgage note payable - The fair value is estimated using cash flow analyses which are based on an assumed market rate of interest or at a rate consistent with the rates on mortgage notes assumed by the Company and are classified as level 2 in the hierarchy. The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at June 30, 2020 and December 31, 2019 , using level 2 inputs. June 30, 2020 December 31, 2019 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 18,340 $ 17,940 $ 23,500 $ 23,399 Interest rate swap liability $ 13,969 $ 13,969 $ 4,808 $ 4,808 Mortgage note payable $ 5,235 $ 5,524 $ 5,288 $ 5,351

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend Declared On August 3, 2020 , the Company’s Board of Directors declared a quarterly common stock dividend in the amount of $0.4225 per share. The dividend is payable on August 28, 2020 to stockholders of record on August 17, 2020 . Highland Update On July 1, 2020, the bankruptcy sale of Highland Hospital was completed and the operator who had been managing the facility acquired its operations and entered into a lease with the Company. The Company provided debtor in possession financing (the “DIP”) to facilitate the sale and, as of the closing of the sale, had an approximately $1.2 million net payable. In addition, the Company continued to have a net investment of $550,000 in a separate note (the “Note”), secured by all assets of Highland Hospital. As of the date of this filing, the DIP and the Note have been combined into a single net receivable balance of approximately $1.4 million .

Summary of Significant Accoun_2

Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 . Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. This interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2020 . All material intercompany accounts and transactions have been eliminated. A novel strain of coronavirus (SARS-CoV-2) was first identified in late 2019, and subsequently declared a global pandemic by the World Health Organization ("COVID-19"). The Company considered the impact of the COVID-19 on the assumptions and estimates used for the three and six months ended June 30, 2020 . The full extent of the future impacts of COVID-19 on the Company's operations is uncertain. A prolonged outbreak could have a material adverse impact on the financial results and business operations of the Company. During the second quarter of 2020, the Company has provided lease concessions to certain tenants in response to the impact of COVID-19, in the form of rent deferrals. The Company has made an election to account for such lease concessions consistent with how those concessions would be accounted for under the current leasing guidance if enforceable rights and obligations for those concessions had already existed in the leases. This election is available for concessions related to the effects of the COVID-19 pandemic that do not result in a substantial increase in our rights as lessor, including concessions that result in the total payments required by the modified lease being substantially the same as or less than total payments required by the original lease. All of the Company’s concessions to date provide for a deferral of payments with no substantive changes to the consideration in the original lease. These deferrals affect the timing, but not the amount, of the lease payments. The Company is accounting for these deferrals as if no changes to the lease were made. Under this accounting, the Company increases its lease receivable as tenant payments accrue and continues to recognize rental income. As of July 31, 2020, the Company has entered into, or anticipates entering into, deferral agreements with up to approximately 20 tenants representing less than one percent of our annualized rent. Pursuant to these agreements, the tenants are generally required to repay the deferred amounts in equal monthly installments during the third and fourth quarters of 2020.
Use of Estimates in the Condensed Consolidated Financial Statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.
Cash and Cash Equivalents	Cash, Cash Equivalents and Restricted Cash
Restricted Cash	Restricted cash consists of amounts held by the lender of our mortgage note payable to provide for future real estate tax, insurance expenditures and tenant improvements related to one property. The carrying amount approximates fair value due to the short term maturity of these investments.
Income Taxes	Income Taxes The Company has elected to be taxed as a real estate investment trust ("REIT"), as defined under the Internal Revenue Code of 1986, as amended (the "Code"). The Company and one subsidiary have also elected for that subsidiary to be treated as a taxable REIT subsidiary ("TRS"), which is subject to federal and state income taxes. No provision has been made for federal income taxes for the REIT; however, the Company has recorded income tax expense or benefit for the TRS to the extent applicable. The Company also evaluates the realizability of its deferred tax assets and will record valuation allowances if it is determined that more likely than not the asset will not be recovered. The Company intends at all times to qualify as a REIT under the Code. The Company must distribute at least 90% per annum of its REIT taxable income to its stockholders (which is computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with generally accepted accounting principles) and meet other requirements to continue to qualify as a REIT. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES" Act) was enacted into law and was immediately effective. The CARES Act includes several tax provisions that allow for the carryback of net operating losses, provides relief from the taxable income limitation on the use of net operating losses carried forward, increases the business interest limitation from 30% to 50%, makes technical corrections to tax depreciation methods for qualified improvement property, and provides payroll tax credits and for the deferral of employer social security payments. The Company does not believe that there have been or will be material impacts to its income taxes related to the CARES Act. The Company will continue to evaluate the tax impact of the CARES Act and any guidance provided by the U.S. Treasury and Internal Revenue Service.
New Accounting Pronouncements	New Accounting Pronouncements Recently Adopted Accounting Pronouncements Financial Instruments-Credit Losses In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debt securities, loans and other instruments, companies are required to use a new current expected credit loss ("CECL") model that generally results in the earlier recognition of allowances for losses. For available-for-sale debt securities with unrealized losses, companies are required to measure credit losses in a manner similar to prior guidance, except that the losses are recognized as allowances rather than as reductions in the amortized cost of the securities. In November 2018, the FASB amended the ASU to clarify that receivables arising from leases would not be within the scope of the ASU but rather would be accounted for under the leasing standard. Companies have to disclose significantly more information, including information they use to track credit quality by year of origination for most financing receivables. Companies must apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. The Company adopted ASU No. 2016-13 on January 1, 2020. The Company did not record an adjustment upon adoption as the impact was determined to be immaterial. However, this standard could impact the Company's financial statements and results of operations in future periods. Recently Issued Accounting Pronouncements Reference Rate Reform In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of June 30, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 4,896 $ 9,031 Restricted cash 351 234 Cash, cash equivalents and restricted cash $ 5,247 $ 9,265
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash and cash equivalents and restricted cash: Balance as of June 30, (Dollars in thousands) 2020 2019 Cash and cash equivalents $ 4,896 $ 9,031 Restricted cash 351 234 Cash, cash equivalents and restricted cash $ 5,247 $ 9,265

Real Estate Leases (Tables)

Real Estate Leases (Tables)	6 Months Ended
	Jun. 30, 2020
Leases [Abstract]
Schedule of future minimum lease payments for operating leases	Future minimum lease payments under the non-cancelable operating leases due the Company for the years ending December 31, as of June 30, 2020 , are as follows (in thousands): 2020 (six months ending December 31) $ 30,417 2021 58,659 2022 55,024 2023 49,996 2024 46,867 2025 and thereafter 299,485 $ 540,448

Real Estate Acquisitions and _2

Real Estate Acquisitions and Dispositions (Tables)	6 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Schedule of acquisitions	Location Property Type (1) Date Acquired Purchase Price Cash Consideration Real Estate Other (2) Square Footage (000's) (000's) (000's) (000's) San Antonio, TX MOB 01/27/20 $ 4,003 $ 4,022 $ 4,036 $ (14 ) 13,500 San Antonio, TX MOB 01/27/20 1,931 1,955 1,961 (6 ) 6,500 Decatur, AL MOB 02/18/20 5,784 5,792 5,777 15 35,943 Ramona, CA SC 03/13/20 4,100 4,124 4,143 (19 ) 11,300 Cuero, TX SC 03/18/20 2,153 2,174 2,207 (33 ) 15,515 Rogers, AR IRF 03/27/20 19,000 18,317 19,042 (725 ) 38,817 Oak Lawn, IL (land) MOB 04/20/20 400 403 421 (18 ) — Germantown, TN SC 04/29/20 3,900 3,949 3,949 — 10,600 Westlake, OH SC 06/05/20 2,443 2,456 2,487 (31 ) 15,057 Columbus, IN (3) SC 06/05/20 1,813 1,828 1,787 41 13,969 Niceville, FL MOB 06/15/20 2,294 2,340 2,344 (4 ) 10,250 Greensburg, PA MOB 06/16/20 3,389 3,484 3,497 (13 ) 15,650 Gardendale, AL MOB 06/24/20 2,948 2,935 2,878 57 12,956 Prattville, AL MOB 06/24/20 4,091 4,111 4,078 33 13,319 $ 58,249 $ 57,890 $ 58,607 $ (717 ) 213,376 (1) MOB - Medical Office Building; SC - Specialty Center; IRF - Inpatient Rehabilitation Facility (2) Includes, but is not limited to, above- and below-market lease intangibles, liabilities assumed, and security deposits. (3) The Company assumed a ground lease in connection with this acquisition that is classified as an operating lease. The present value of future lease payments and the right-of-use asset, each totaling approximately $0.2 million, are included in other liabilities and other assets, respectively, on the Company's Condensed Consolidated Balance Sheets.
Schedule of assets acquired and liabilities assumed	The following table summarizes the relative fair values of the assets acquired and liabilities assumed in the property acquisitions for the six months ended June 30, 2020 . Relative Fair Value Estimated Useful Life (in thousands) (in years) Land and land improvements $ 11,323 8.5 Building and building improvements 41,709 30.2 Intangibles: At-market lease intangibles 5,575 5.4 Above-market lease intangibles 292 4.8 Below-market lease intangibles (111 ) 3.1 Total intangibles 5,756 Accounts receivable and other assets assumed 247 Accounts payable, accrued liabilities and other liabilities assumed (807 ) Prorated rent, interest and operating expense reimbursement amounts collected (338 ) Total cash consideration $ 57,890

Debt, net (Tables)

Debt, net (Tables)	6 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Schedule of debt	The table below details the Company's debt as of June 30, 2020 and December 31, 2019 . Balance as of (Dollars in thousands) June 30, 2020 December 31, 2019 Maturity Dates Revolving Credit Facility $ 18,000 $ 15,000 3/23 A-1 Term Loan, net 49,871 49,833 3/22 A-2 Term Loan, net 49,801 49,775 3/24 A-3 Term Loan, net 74,479 74,433 3/26 Mortgage Note Payable, net 5,158 5,202 5/24 $ 197,309 $ 194,243

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of derivative instruments on balance sheet	The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 . Asset Derivatives Fair Value at Liability Derivatives Fair Value at June 30, 2020 December 31, 2019 Balance Sheet Classification June 30, 2020 December 31, 2019 Balance Sheet Classification Interest rate swaps $ — $ — Other assets $ 13,969 $ 4,808 Other Liabilities
Schedule of derivative gain (loss)	The table below details the location in the financial statements of the gain or loss recognized on interest rate derivatives designated as cash flow hedges for the three and six months ended June 30, 2020 and 2019 . Three Months Ended Six Months Ended (Dollars in thousands) 2020 2019 2020 2019 Amount of unrealized loss recognized in OCI on derivative $ (1,317 ) $ (4,032 ) $ (10,193 ) $ (5,245 ) Amount of loss (gain) reclassified from AOCI into interest expense $ 774 $ (95 ) $ 1,032 $ (157 ) Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded $ 2,183 $ 2,251 $ 4,432 $ 4,305

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Schedule of reconciliation of common stock	The following table provides a reconciliation of the beginning and ending common stock balances for the six months ended June 30, 2020 and for the year ended December 31, 2019 : Six Months Ended Year Ended December 31, 2019 Balance, beginning of period 21,410,578 18,634,502 Issuance of common stock 1,189,545 2,554,247 Restricted stock-based awards 126,018 221,829 Balance, end of period 22,726,141 21,410,578
Schedule of ATM Program	As of June 30, 2020 , the Company had approximately $251.6 million remaining that may be issued under the ATM Program. Three Months Ended Six Months Ended Shares issued 578,759 1,189,545 Net proceeds received (in millions) $ 23.7 $ 50.6 Average gross sales price per share $ 41.70 $ 43.39

Net Income Per Common Share (Ta

Net Income Per Common Share (Tables)	6 Months Ended
	Jun. 30, 2020
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the computation of basic and diluted net income per common share for the three and six months ended June 30, 2020 and 2019 , respectively. Three Months Ended Six Months Ended (Dollars in thousands, except per share data) 2020 2019 2020 2019 Net income $ 4,526 $ 2,066 $ 8,626 $ 3,516 Participating securities' share in earnings (432 ) (351 ) (855 ) (652 ) Net income, less participating securities' share in earnings $ 4,094 $ 1,715 $ 7,771 $ 2,864 Weighted average Common Shares outstanding Weighted average Common Shares outstanding 22,285,565 19,055,110 22,008,998 18,896,274 Unvested restricted shares (1,021,990 ) (809,442 ) (1,009,901 ) (795,301 ) Weighted average Common Shares outstanding–Basic 21,263,575 18,245,668 20,999,097 18,100,973 Dilutive potential common shares — — — — Weighted average Common Shares outstanding –Diluted 21,263,575 18,245,668 20,999,097 18,100,973 Basic Net Income per Common Share $ 0.19 $ 0.09 $ 0.37 $ 0.16 Diluted Net Income per Common Share $ 0.19 $ 0.09 $ 0.37 $ 0.16

Incentive Plan (Tables)

Incentive Plan (Tables)	6 Months Ended
	Jun. 30, 2020
Share-based Payment Arrangement [Abstract]
Summary of nonvested restricted stock activity	A summary of the activity under the Company's 2014 Incentive Plan, as amended, for the three and six months ended June 30, 2020 and 2019 is included in the table below, as well as compensation expense recognized from the amortization of the value of shares over the applicable vesting periods. Three Months Ended Six Months Ended (Dollars in thousands) 2020 2019 2020 2019 Stock-based awards, beginning of period 1,013,797 794,177 909,892 709,487 Stock in lieu of compensation 5,510 15,004 55,755 57,529 Stock awards 16,603 25,995 70,263 68,160 Total stock granted 22,113 40,999 126,018 125,689 Vested shares (15,910 ) (21,424 ) (15,910 ) (21,424 ) Stock-based awards, end of period 1,020,000 813,752 1,020,000 813,752 Amortization expense $ 1,070 $ 899 $ 2,090 $ 1,752

Other Assets, net (Tables)

Other Assets, net (Tables)	6 Months Ended
	Jun. 30, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Assets	Other assets, net on the Company's Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019 are detailed in the table below. Balance as of (Dollars in thousands) June 30, 2020 December 31, 2019 Notes receivable $ 18,340 $ 23,500 Lease and interest receivables 2,821 3,021 Straight-line rent receivables 6,885 5,267 Prepaid assets 602 488 Deferred financing costs, net 586 693 Leasing commissions, net 980 875 Deferred tax asset 575 595 Above-market intangible assets, net 414 144 Right-of-use leased asset 385 139 Other 480 457 $ 32,068 $ 35,179
Schedule of VIEs	The VIEs that we have identified at June 30, 2020 are summarized in the table below. Classification Carrying Amount (in millions) Maximum Exposure to Loss (in millions) Note receivable $ 17.8 $ 17.8 Note receivable $ 0.6 $ 0.6

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value, by Balance Sheet Grouping	The table below details the fair values and carrying values for our notes receivable, interest rate swaps, and mortgage note payable at June 30, 2020 and December 31, 2019 , using level 2 inputs. June 30, 2020 December 31, 2019 (Dollars in thousands) Carrying Value Fair Value Carrying Value Fair Value Notes receivable $ 18,340 $ 17,940 $ 23,500 $ 23,399 Interest rate swap liability $ 13,969 $ 13,969 $ 4,808 $ 4,808 Mortgage note payable $ 5,235 $ 5,524 $ 5,288 $ 5,351

Summary of Significant Accoun_4

Summary of Significant Accounting Policies Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands, ft² in Millions	Jul. 31, 2020tenant	Jun. 30, 2020USD ($)ft²statereal_estate_property	Dec. 31, 2019USD ($)	Jun. 30, 2019USD ($)	Dec. 31, 2018USD ($)
Accounting Policies [Abstract]
Total real estate properties		$ 664,687	$ 602,852
Number of real estate properties | real_estate_property		131
Number of states | state		33
Area of real estate property (in square feet) | ft²		2.8
Cash and cash equivalents		$ 4,896	1,730	$ 9,031
Restricted cash		351	293	234
Cash, cash equivalents and restricted cash		$ 5,247	$ 2,023	$ 9,265	$ 2,392
COVID-19 | Subsequent Event
Unusual or Infrequent Item, or Both [Line Items]
Number of tenants with deferral agreements | tenant	20
Percentage of annualized rent with deferral agreements	1.00%

Real Estate Leases Real Estate

Real Estate Leases Real Estate Leases (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Real Estate [Line Items]
2020 (six months ending December 31)	$ 30,417		$ 30,417
2021	58,659		58,659
2022	55,024		55,024
2023	49,996		49,996
2024	46,867		46,867
2025 and thereafter	299,485		299,485
Total	540,448		540,448
Straight line rent	700	$ 400	1,604	$ 749
Security deposit	4,100		4,100		$ 3,500
Other Liabilities
Real Estate [Line Items]
Deferred revenue	$ 2,100		$ 2,100		$ 2,000

Real Estate Acquisitions and _3

Real Estate Acquisitions and Dispositions Real Estate Acquisitions and Dispositions - Real Estate Acquisitions (Details) $ in Thousands	3 Months Ended			6 Months Ended
	Jun. 30, 2020USD ($)real_estate_property	Mar. 31, 2020real_estate_property	Jun. 30, 2019USD ($)	Jun. 30, 2020USD ($)	Jun. 30, 2019USD ($)	Dec. 31, 2019
Business Acquisition [Line Items]
Proceeds from sale of land	$ 300
Loss on sale of land	$ (313)		$ 0	$ (313)	$ 0
Operating Lease, Liability, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilities			us-gaap:OtherLiabilities
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets			us-gaap:OtherAssets		us-gaap:OtherAssets
Acquisition Of Properties During 2nd Quarter 2020
Business Acquisition [Line Items]
Number of real estate properties acquired | real_estate_property	7
Percentage of properties that were leased at acquisition	100.00%
Pro forma information, revenue of acquiree since acquisition date, actual	$ 100
Pro forma information, earnings or loss of acquiree since acquisition date, actual	4,000
Transaction costs	400			$ 400
Acquisition Of Properties During 1st Quarter 2020
Business Acquisition [Line Items]
Number of real estate properties acquired | real_estate_property		6
Percentage of properties that were leased at acquisition		98.20%
Pro forma information, revenue of acquiree since acquisition date, actual				1,400
Pro forma information, earnings or loss of acquiree since acquisition date, actual				800
Transaction costs	$ 200			$ 200

Real Estate Acquisitions and _4

Real Estate Acquisitions and Dispositions Real Estate Acquisitions and Dispositions - Real Estate Acquisitions - Additional Information (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)ft²	Dec. 31, 2019USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Square footage (in square feet) | ft²	2,800,000
ROU asset	$ 385	$ 139
Columbus, IN
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
ROU asset	200
Future lease payments	200
Acquisition Of Properties In 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	58,249
Cash Consideration	57,890
Real Estate	58,607
Other	$ (717)
Square footage (in square feet) | ft²	213,376
Acquisition Of Properties During 1st Quarter 2020 | San Antonio, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 4,003
Cash Consideration	4,022
Real Estate	4,036
Other	$ (14)
Square footage (in square feet) | ft²	13,500
Acquisition Of Properties During 1st Quarter 2020 | San Antonio, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 1,931
Cash Consideration	1,955
Real Estate	1,961
Other	$ (6)
Square footage (in square feet) | ft²	6,500
Acquisition Of Properties During 1st Quarter 2020 | Decatur, AL
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 5,784
Cash Consideration	5,792
Real Estate	5,777
Other	$ 15
Square footage (in square feet) | ft²	35,943
Acquisition Of Properties During 1st Quarter 2020 | Ramona, CA
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 4,100
Cash Consideration	4,124
Real Estate	4,143
Other	$ (19)
Square footage (in square feet) | ft²	11,300
Acquisition Of Properties During 1st Quarter 2020 | Cuero, TX
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,153
Cash Consideration	2,174
Real Estate	2,207
Other	$ (33)
Square footage (in square feet) | ft²	15,515
Acquisition Of Properties During 1st Quarter 2020 | Rogers, AR
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 19,000
Cash Consideration	18,317
Real Estate	19,042
Other	$ (725)
Square footage (in square feet) | ft²	38,817
Acquisition Of Properties During 2nd Quarter 2020 | Oak Lawn, IL (land)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 400
Cash Consideration	403
Real Estate	421
Other	$ (18)
Square footage (in square feet) | ft²	0
Acquisition Of Properties During 2nd Quarter 2020 | Germantown, TN
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 3,900
Cash Consideration	3,949
Real Estate	3,949
Other	$ 0
Square footage (in square feet) | ft²	10,600
Acquisition Of Properties During 2nd Quarter 2020 | Westlake, OH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,443
Cash Consideration	2,456
Real Estate	2,487
Other	$ (31)
Square footage (in square feet) | ft²	15,057
Acquisition Of Properties During 2nd Quarter 2020 | Columbus, IN
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 1,813
Cash Consideration	1,828
Real Estate	1,787
Other	$ 41
Square footage (in square feet) | ft²	13,969
Acquisition Of Properties During 2nd Quarter 2020 | Niceville, FL
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,294
Cash Consideration	2,340
Real Estate	2,344
Other	$ (4)
Square footage (in square feet) | ft²	10,250
Acquisition Of Properties During 2nd Quarter 2020 | Greensburg, PA
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 3,389
Cash Consideration	3,484
Real Estate	3,497
Other	$ (13)
Square footage (in square feet) | ft²	15,650
Acquisition Of Properties During 2nd Quarter 2020 | Gardendale, AL
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 2,948
Cash Consideration	2,935
Real Estate	2,878
Other	$ 57
Square footage (in square feet) | ft²	12,956
Acquisition Of Properties During 2nd Quarter 2020 | Prattville, AL
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Purchase Price	$ 4,091
Cash Consideration	4,111
Real Estate	4,078
Other	$ 33
Square footage (in square feet) | ft²	13,319

Real Estate Acquisitions and _5

Real Estate Acquisitions and Dispositions Real Estate Acquisitions and Dispositions - Assets Acquired and Liabilities Assumed (Details) - Series of Individually Immaterial Asset Acquisitions $ in Thousands	6 Months Ended
	Jun. 30, 2020USD ($)
Business Acquisition [Line Items]
Land and land improvements	$ 11,323
Building and building improvements	41,709
Below-market lease intangibles	$ (111)
Below market lease useful life (in years)	3 years 1 month 6 days
Total intangibles	$ 5,756
Accounts receivable and other assets assumed	247
Accounts payable, accrued liabilities and other liabilities assumed	(807)
Prorated rent, interest and operating expense reimbursement amounts collected	(338)
Total cash consideration	57,890
At-market lease intangibles
Business Acquisition [Line Items]
Lease intangibles	$ 5,575
Intangibles useful life (in years)	5 years 4 months 24 days
Above-market lease intangibles
Business Acquisition [Line Items]
Lease intangibles	$ 292
Intangibles useful life (in years)	4 years 9 months 18 days
Land and land improvements
Business Acquisition [Line Items]
Useful life (in years)	8 years 6 months
Building and building improvements
Business Acquisition [Line Items]
Useful life (in years)	30 years 2 months 12 days

Debt, net Debt, net - Schedule

Debt, net Debt, net - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt, net	$ 197,309	$ 194,243
Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	175,000
Mortgage Note Payable, net
Debt Instrument [Line Items]
Debt, net	5,158	5,202
Revolving Credit Facility | Line of Credit | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	18,000	15,000
A-1 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	49,871	49,833
A-2 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	49,801	49,775
A-3 Term Loan, net | Term Loan | Third Amended And Restated Credit Facility
Debt Instrument [Line Items]
Debt, net	$ 74,479	$ 74,433

Debt, net Debt, net - Narrative

Debt, net Debt, net - Narrative (Details)	Mar. 29, 2019USD ($)option	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)
Line of Credit Facility [Line Items]
Amount outstanding		$ 197,309,000	$ 194,243,000
Third Amended And Restated Credit Facility | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 175,000,000
Unused borrowing commitment fee percentage	0.35%
Amount outstanding		$ 175,000,000
Weighted average interest rate percentage		4.569%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	2.30%
Third Amended And Restated Credit Facility | Base Rate | Minimum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility | Base Rate | Maximum | Term Loan
Line of Credit Facility [Line Items]
Variable rate percentage	1.30%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 150,000,000
Number of options to extend | option	1
Length of extension	12 months
Amount outstanding		$ 18,000,000	15,000,000
Remaining borrowing capacity		$ 132,000,000
Weighted average interest rate percentage		2.06%
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	1.90%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Minimum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.25%
Third Amended And Restated Credit Facility | Revolving Credit Facility | Base Rate | Maximum | Line of Credit
Line of Credit Facility [Line Items]
Variable rate percentage	0.90%
Third Amended And Restated Credit Facility | Credit Facility, Accordion Feature
Line of Credit Facility [Line Items]
Maximum borrowing capacity	$ 525,000,000
Third Amended And Restated Credit Facility | A-1 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	5 years
Amount outstanding		$ 49,871,000	49,833,000
Third Amended And Restated Credit Facility | A-2 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 50,000,000
Debt term	7 years
Amount outstanding		49,801,000	49,775,000
Third Amended And Restated Credit Facility | A-3 Term Loan, net | Term Loan
Line of Credit Facility [Line Items]
Face amount	$ 75,000,000
Debt term	7 years
Amount outstanding		$ 74,479,000	$ 74,433,000
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 1 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.25%
Percentage of borrowing capacity outstanding	33.30%
Third Amended And Restated Credit Facility | Revolving Credit Facility, Unused Borrowing Capacity Rate 2 | Line of Credit
Line of Credit Facility [Line Items]
Unused borrowing commitment fee percentage	0.35%
Percentage of borrowing capacity outstanding	33.30%

Derivative Financial Instrume_3

Derivative Financial Instruments Derivative Financial Instruments - Narrative (Details)	6 Months Ended
	Jun. 30, 2020USD ($)derivative_instrument
Derivative [Line Items]
Cash flow hedges reclassified to interest expense	$ 3,700,000
Cash Flow Hedging | Interest Rate Contract
Derivative [Line Items]
Number outstanding interest rate derivatives | derivative_instrument	7
Notional amount	$ 175,000,000
Termination value	14,500,000
Cash Flow Hedging | Interest Rate Swap | Designated as Hedging Instrument
Derivative [Line Items]
Interest rate swap liability	$ 14,500,000

Derivative Financial Instrume_4

Derivative Financial Instruments Derivative Financial Instruments - Fair Value Balance Sheet (Details) - Cash Flow Hedging - Interest rate swaps - Designated as Hedging Instrument - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Derivatives, Fair Value [Line Items]
Derivative liability	$ 14,500
Other assets
Derivatives, Fair Value [Line Items]
Derivative asset	0	$ 0
Other Liabilities
Derivatives, Fair Value [Line Items]
Derivative liability	$ 13,969	$ 4,808

Derivative Financial Instrume_5

Derivative Financial Instruments Derivative Financial Instruments- Cash Flow Hedging (Details) - Interest Rate Contract - Cash Flow Hedging - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of unrealized loss recognized in OCI on derivative	$ (1,317)	$ (4,032)	$ (10,193)	$ (5,245)
Interest Expense
Derivative Instruments, Gain (Loss) [Line Items]
Amount of loss (gain) reclassified from AOCI into interest expense	774	(95)	1,032	(157)
Total interest expense presented in the Condensed Consolidated Statements of Income in which the effects of the cash flow hedges are recorded	$ 2,183	$ 2,251	$ 4,432	$ 4,305

Stockholders' Equity Stockholde

Stockholders' Equity Stockholders' Equity - Reconciliation of Common Stock (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance, beginning of period (in shares)	21,410,578	18,634,502
Issuance of common stock (in shares)	1,189,545	2,554,247
Restricted stock-based awards (in shares)	126,018	221,829
Balance, end of period (in shares)	22,726,141	21,410,578

Stockholders' Equity Stockhol_2

Stockholders' Equity Stockholders' Equity - Equity Offering (Details) - At The Market Offering Program - Common Stock - USD ($) $ / shares in Units, $ in Millions	Nov. 05, 2019	Jun. 30, 2020	Jun. 30, 2020
Subsidiary, Sale of Stock [Line Items]
Value of shares authorized	$ 360
Remaining availability under ATM program		$ 251.6	$ 251.6
Shares issued (in shares)		578,759	1,189,545
Net proceeds received		$ 23.7	$ 50.6
Average gross sales price per share (in dollars per share)		$ 41.70	$ 43.39

Net Income Per Common Share Net

Net Income Per Common Share Net Income Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Earnings Per Share [Abstract]
Net income	$ 4,526	$ 2,066	$ 8,626	$ 3,516
Participating securities' share in earnings	(432)	(351)	(855)	(652)
Net income, less participating securities' share in earnings	$ 4,094	$ 1,715	$ 7,771	$ 2,864
Weighted average Common Shares outstanding
Weighted average Common Shares outstanding (in shares)	22,285,565	19,055,110	22,008,998	18,896,274
Unvested restricted shares (in shares)	(1,021,990)	(809,442)	(1,009,901)	(795,301)
Weighted average Common Shares outstanding–Basic (in shares)	21,263,575	18,245,668	20,999,097	18,100,973
Dilutive potential common share (in shares)	0	0	0	0
Weighted average Common Shares outstanding –Diluted (in shares)	21,263,575	18,245,668	20,999,097	18,100,973
Basic Net Income per Common Share (in dollars per share)	$ 0.19	$ 0.09	$ 0.37	$ 0.16
Diluted Net Income per Common Share (in dollars per share)	$ 0.19	$ 0.09	$ 0.37	$ 0.16

Incentive Plan Incentive Plan -

Incentive Plan Incentive Plan - Restricted Stock Activity (Details) - 2014 Incentive Plan - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Restricted Common Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Stock-based awards, beginning of period (in shares)	1,013,797	794,177	909,892	709,487
Granted (in shares)	22,113	40,999	126,018	125,689
Vested (in shares)	(15,910)	(21,424)	(15,910)	(21,424)
Stock-based awards, end of period (in shares)	1,020,000	813,752	1,020,000	813,752
Amortization expense	$ 1,070	$ 899	$ 2,090	$ 1,752
Restricted Common Stock, Stock in Lieu of Compensation
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	5,510	15,004	55,755	57,529
Restricted Common Stock, Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Granted (in shares)	16,603	25,995	70,263	68,160

Other Assets, net Other Assets,

Other Assets, net Other Assets, net - Other Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Notes receivable	$ 18,340	$ 23,500
Lease and interest receivables	2,821	3,021
Straight-line rent receivables	6,885	5,267
Prepaid assets	602	488
Deferred financing costs, net	586	693
Leasing commissions, net	980	875
Deferred tax asset	575	595
Above-market intangible assets, net	414	144
Right-of-use leased asset	385	139
Other	480	457
Other assets, net	$ 32,068	$ 35,179
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	us-gaap:OtherAssets	us-gaap:OtherAssets

Other Assets, net Other Asset_2

Other Assets, net Other Assets, net - Narrative (Details) $ in Thousands	3 Months Ended	6 Months Ended
	Mar. 31, 2020USD ($)	Jun. 30, 2020USD ($)hospital	Dec. 31, 2019USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 18,340	$ 23,500
Long-Term Acute Care Hospitals
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital		7
Inpatient Rehabilitation Facilities
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of properties used to secure notes by borrower | hospital		1
Note Receivable 1 | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 17,800
Note receivable interest rate		9.00%
Revolving Credit Facility | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable		$ 3,000
DIP Financing | Highland Hospital | Notes Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes receivable	$ 2,500	$ 600
Note receivable interest rate		10.00%
Payment to acquire finance receivable	1,750
Payment received	$ 1,200

Other Assets, net Other Asset_3

Other Assets, net Other Assets, net - VIEs (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Variable Interest Entity [Line Items]
Carrying Amount	$ 18,340	$ 23,500
VIEs | Note receivable
Variable Interest Entity [Line Items]
Carrying Amount	17,800
Maximum Exposure to Loss	17,800
VIEs | Note receivable
Variable Interest Entity [Line Items]
Carrying Amount	600
Maximum Exposure to Loss	$ 600

Fair Value of Financial Instr_3

Fair Value of Financial Instruments Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	$ 18,340	$ 23,500
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	18,340	23,500
Mortgage note payable	5,235	5,288
Carrying Value | Interest rate swap liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap liability	13,969	4,808
Fair Value | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Notes receivable	17,940	23,399
Mortgage note payable	5,524	5,351
Fair Value | Interest rate swap liability | Fair Value, Inputs, Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate swap liability	$ 13,969	$ 4,808

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Thousands	Aug. 03, 2020	Jul. 01, 2020	Jun. 30, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Financing receivable			$ 18,340	$ 23,500
Subsequent Event
Subsequent Event [Line Items]
Dividend declared (in dollars per share)	$ 0.4225
Highland Hospital | Subsequent Event
Subsequent Event [Line Items]
Financing receivable		$ 1,400
Highland Hospital | DIP Financing | Subsequent Event
Subsequent Event [Line Items]
Financing receivable		1,200
Highland Hospital | Notes Receivable | Subsequent Event
Subsequent Event [Line Items]
Financing receivable		$ 550